The prognosis of patients with small cell carcinoma is reported to be poor.'-6 The Medical
Research Council Working Party, evaluating different methods of therapy for carcinoma of the bronchus, concluded in its report in November 1966 "that despite its very limited effect, radical radiotherapy is preferable to surgery in the treatment of small cell or oat cell carcinoma of the bronchus. "7 This investigation and the conclusions reached have been questioned on the grounds that in all cases the diagnosis was made by rigid bronchoscopy and that too many surgeons were concerned in patient selection.8 9 However, surgery is often withheld since surgical results are still generally considered no better than those obtained with other modes of therapy. If this attitude persists as the incidence of preoperative histological typing increases with the introduction of the fibreoptic bronchoscope and greater familiarity with the technique of needle biopsy, more patients with small cell carcinoma will be denied surgery.
It has been our policy to exclude from surgery only those patients who If the operative mortality after resection for small cell carcinoma is high, as appears to be the case, this may reflect both the radical approach 8 3 Abnormal bronchoscopy (negative biopsy) 13 5 Abnormal bronchoscopy (positive biopsy) 15 3 Sputum cytology only In the small cell group virtually all deaths from recurrent disease occur within 12 months of operation. In the squamous carcinoma group, deaths from recurrence accumulate steadily over three to four years. These curves illustrate the more aggressive nature of the small cell tumour.
As would be expected a greater percentage of surgical cures have been obtained in the squamous group. However, the five-year survival figure of 52% may not be representative as this number of cases is a small percentage of the total undergoing resection for squamous carcinoma between 1959-74. 
Discussion
The incidence of long-term survival in our series of patients justifies the incumbent mortality, morbidity, and discomfort of any operative procedure.
The five-year survival rate in other reported series varies between 0% and 36%. The highest survival rate of 36% reported by Higgins et a113 reflects the peripheral situation of the resected tumours. Friese et al14 reported a 37-5% survival rate in patients undergoing lobectomy for small -ell carcinoma. They, like ourselves, do not regard mediastinal node involvement as a contraindication to pulmonary resection. The number of surviving patients in our series who had histological evidence of hilar (64%) and mediastinal (18%) gland involvement clearly illustrates the benefit of radical surgery.
Postmortem findings in a series of patients with oat cell carcinoma reported by Takita et all suggested that the spread of the disease is not uniformly rapid and fatal. In addition, Goldman5 reported an association between improved survival and varying histological appearances with some features of differentiation such as rosette formation and pallisading of cells. There are histological and histochemical similarities between the small cell carcinoma and the carcinoid tumour,15 and attention has been drawn to the "behavioural overlap" between the oat cell tumour and the atypical carcinoid. Long-term survival may occur when the tumour is at one end of a spectrum of malignancy.
Alternative methods of therapy with single or multiple agent chemotherapy have so far produced only isolated incidences of long-term survival although they do provide a high rate of remission and worthwhile palliation.'6 Meyer'7 recommended surgical resection in selected cases followed by a multiple agent chemotherapeutic regime, at the same time calling for controlled trials to establish the usefulness of adjuvant therapy.
At present, we conclude that surgery offers the best chance of long-term survival in small cell carcinoma of the bronchus. Avoidance of delay in diagnosis, early referral, and radical surgery, where possible, iare strongly recommended. 
